Polycyclic aromatic hydrocarbon exposure and pediatric asthma in children: a case-control study

Nasser M Al-Daghri1, Majed S Alokail, Sherif H Abd-Alrahman

  • 1Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia. ndaghri@ksu.edu.sa

Insights

Elevated serum polycyclic aromatic hydrocarbons (PAHs) are linked to childhood asthma in Saudi children. Specific PAHs correlate with asthma biomarkers, indicating their role in the disease.

Area of Science:

  • Environmental Health
  • Pediatric Allergy and Immunology
  • Toxicology

Background:

  • Childhood asthma is a significant health issue in Arab populations.
  • Environmental pollution is a suspected contributor to asthma and respiratory symptoms.
  • This study investigates the link between serum polycyclic aromatic hydrocarbons (PAHs) and asthma in Saudi children.

Purpose of the Study:

  • To evaluate the association between serum PAH levels and asthma and allergic outcomes in Saudi children up to 15 years old.
  • To test the hypothesis that increased serum PAHs are associated with allergy, asthma, or respiratory symptoms.

Main Methods:

  • A cohort of 195 Saudi children (98 with asthma, 97 healthy controls) was selected from the Riyadh Cohort Study.
  • Asthma diagnosis was confirmed using established pediatric criteria and medication records.

Main Results:

  • Significant differences in asthma-related markers were observed between asthmatic and non-asthmatic children.
  • Specific PAHs, including naphthalene and benzo(e)acephenanthrylene, showed strong associations with childhood asthma.
  • PAH levels correlated with key asthma biomarkers such as IgE, resistin, and various cytokines (IL-4, IL-5, IL-8, IL-10).

Conclusions:

  • Specific polycyclic aromatic hydrocarbons play a critical role in the development of childhood asthma.
  • Findings underscore the impact of environmental pollutants on pediatric respiratory health.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...